Jones, Steven R.

Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile

Martin, S. S., Blaha, M. J., Elshazly, M. B., Toth, P. P., Kwiterovich, P. O., Blumenthal, R. S., & Jones, S. R. (2013) · JAMA

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 883

Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association

Bays, H. E., Toth, P. P., Kris-Etherton, P. M., Abate, N., Aronne, L. J., Brown, W. V., Gonzalez-Campoy, J. M., Jones, S. R., Kumar, R., La Forge, R., et al. (2013) · Journal of Clinical Lipidology

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Disease and Adiposity

Cited by 521

Inflammation and cardiovascular disease: From mechanisms to therapeutics

Alfaddagh, A., Martin, S. S., Leucker, T. M., Michos, E. D., Blaha, M. J., Lowenstein, C. J., Jones, S. R., & Toth, P. P. (2020) · American Journal of Preventive Cardiology

Atherosclerosis and Cardiovascular DiseasesLipoproteins and Cardiovascular Health

Cited by 473

Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: A primary prevention study

Quispe, R., Martin, S. S., Michos, E. D., Lamba, I., Blumenthal, R. S., Saeed, A., Lima, J., Puri, R., Nomura, S., Tsai, M., et al. (2021) · European Heart Journal

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 441

Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications

Martin, S. S., Blaha, M. J., Elshazly, M. B., Brinton, E. A., Toth, P. P., McEvoy, J. W., Joshi, P. H., Kulkarni, K. R., Mize, P. D., Kwiterovich, P. O., et al. (2013) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 428

mActive: A Randomized Clinical Trial of an Automated mHealth Intervention for Physical Activity Promotion

Martin, S. S., Feldman, D. I., Blumenthal, R. S., Jones, S. R., Post, W. S., McKibben, R. A., Michos, E. D., Ndumele, C. E., Ratchford, E. V., Coresh, J., et al. (2015) · Journal of the American Heart Association

Mobile Health and mHealth ApplicationsPhysical Activity and Health

Cited by 267

Effects of Coenzyme Q10 on Statin-Induced Myopathy

Banach, M., Serban, C., Sahebkar, A., Ursoniu, S., Rysz, J., Muntner, P., Toth, P. P., Jones, S. R., Rizzo, M., Glasser, S. P., et al. (2015) · Mayo Clinic Proceedings

Coenzyme Q10 studies and effectsLipoproteins and Cardiovascular Health

Cited by 198

Statin therapy and plasma coenzyme Q10 concentrations—A systematic review and meta-analysis of placebo-controlled trials

Banach, M., Serban, C., Ursoniu, S., Rysz, J., Muntner, P., Toth, P. P., Jones, S. R., Rizzo, M., Glasser, S. P., Watts, G. F., et al. (2015) · Pharmacological Research

Coenzyme Q10 studies and effectsLipoproteins and Cardiovascular Health

Cited by 195

Remnant lipoprotein cholesterol and incident coronary heart disease: the Jackson Heart and Framingham offspring cohort studies

Joshi, P. H., Khokhar, A. A., Massaro, J. M., Lirette, S. T., Griswold, M. E., Martin, S. S., Blaha, M. J., Kulkarni, K. R., Correa, A., D'Agostino, R. B., et al. (2016) · Journal of the American Heart Association

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 177

Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel: This paper is also published in parallel in Archives of Medical Science [Banach M, Rizzo M, Toth PP, et al. Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Arch Med Sci 2015; 11(1): 1–23]

Banach, M., Rizzo, M., Toth, P. P., Farnier, M., Davidson, M. H., Al-Rasadi, K., Aronow, W. S., Athyros, V., Djuric, D. M., Ezhov, M. V., et al. (2015) · Expert Opinion on Drug Safety

Lipoproteins and Cardiovascular HealthPharmacovigilance and Adverse Drug Reactions

Cited by 162

Fasting versus nonfasting and low-density lipoprotein cholesterol accuracy

Sathiyakumar, V., Park, J., Golozar, A., Lazo, M., Quispe, R., Guallar, E., Blumenthal, R. S., Jones, S. R., & Martin, S. S. (2018) · Circulation

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 122

Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease

Elshazly, M. B., Mani, P., Nissen, S., Brennan, D. M., Clark, D., Martin, S., Jones, S. R., Quispe, R., Donnellan, E., Nicholls, S. J., et al. (2020) · European Journal of Preventive Cardiology

Lipoproteins and Cardiovascular HealthCoronary Interventions and Diagnostics

Cited by 103

Physical fitness and hypertension in a population at risk for cardiovascular disease: the Henry Ford Exercise Testing (FIT) Project.

Juraschek, S. P., Blaha, M. J., Whelton, S. P., Blumenthal, R., Jones, S. R., Keteyian, S. J., Schairer, J., Brawner, C. A., & Al‐Mallah, M. H. (2014) · Journal of the American Heart Association

Cardiovascular and exercise physiologyBlood Pressure and Hypertension Studies

Cited by 97

Non–High-Density Lipoprotein Cholesterol, Guideline Targets, and Population Percentiles for Secondary Prevention in 1.3 Million Adults

Elshazly, M. B., Martin, S. S., Blaha, M. J., Joshi, P. H., Toth, P. P., McEvoy, J. W., Al-Hijji, M. A., Kulkarni, K. R., Kwiterovich, P. O., Blumenthal, R. S., et al. (2013) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 68

Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines

Sathiyakumar, V., Park, J., Quispe, R., Elshazly, M. B., Michos, E. D., Banach, M., Toth, P. P., Whelton, S. P., Blumenthal, R. S., Jones, S. R., et al. (2018) · Circulation

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 58

Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol <70 mg/dL compared with a novel low-density lipoprotein estimation method

Whelton, S. P., Meeusen, J. W., Donato, L. J., Jaffe, A. S., Saenger, A., Sokoll, L. J., Blumenthal, R. S., Jones, S. R., & Martin, S. S. (2017) · Journal of Clinical Lipidology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 48

The association between triglyceride-rich lipoproteins, circulating leukocytes, and low-grade inflammation: The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)

Cesena, F. Y., Generoso, G., Santos, R. D., Pereira, A. C., Blaha, M. J., Jones, S. R., Toth, P. P., Lotufo, P. A., Bittencourt, M. S., & Benseñor, I. M. (2023) · Journal of Clinical Lipidology

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 15

Importance of the triglyceride level in identifying patients with a Type III Hyperlipoproteinemia phenotype using the ApoB algorithm

Varghese, B., Park, J., Chew, E., Sajja, A., Brownstein, A., Pallazola, V. A., Sathiyakumar, V., Jones, S. R., Sniderman, A. D., & Martin, S. S. (2021) · Journal of Clinical Lipidology

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 12

81Efficacy and safety of alternate-day versus daily dosing of statins: a systematic review and meta-analysis

Awad, K., Mikhailidis, D. P., Toth, P. P., Jones, S. R., Moriarty, P., Lip, G. Y. H., Muntner, P., Catapano, A. L., Pencina, M. J., Rosenson, R. S., et al. (2017) · European Heart Journal

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 2